PRTT (Protect Pharmaceutical) EV-to-EBIT: 0.00 (As of Jul. 18, 2026)

Author:

Vera Yuan

Director of Data and Quant Analytics at GuruFocus

Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.

View Profile →

Reviewed by:

Charlie Tian

Founder & CEO of GuruFocus

Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

View Profile →

What is Protect Pharmaceutical EV-to-EBIT?

Protect Pharmaceutical PRTT EV-to-EBIT is 0.00 as of Jul. 18, 2026.

EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, Protect Pharmaceutical's Enterprise Value is $0.00 Mil. Protect Pharmaceutical's EBIT for the trailing twelve months (TTM) ended in Jun. 2018 was $-0.00 Mil. Therefore, Protect Pharmaceutical's EV-to-EBIT for today is 0.00.

The historical rank and industry rank for Protect Pharmaceutical's EV-to-EBIT or its related term are showing as below:

PRTT's EV-to-EBIT is not ranked ^*
in the Transportation industry.
Industry Median: 12.35
* Ranked among companies with meaningful EV-to-EBIT only.

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %. Protect Pharmaceutical's Enterprise Value for the quarter that ended in Jun. 2018 was $0.89 Mil. Protect Pharmaceutical's EBIT for the trailing twelve months (TTM) ended in Jun. 2018 was $-0.00 Mil. Protect Pharmaceutical's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Jun. 2018 was -0.11%.

Protect Pharmaceutical (OTCPK:PRTT) EV-to-EBIT Explanation

This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %.

Protect Pharmaceutical's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Jun. 2018 is calculated as:

Earnings Yield (Joel Greenblatt) % (Q: Jun. 2018 )	=	EBIT	/	Enterprise Value (Q: Jun. 2018 )
	=	-0.001	/	0.88981
	=	-0.11 %

Protect Pharmaceutical's Enterprise Value for the quarter that ended in Jun. 2018 was $0.89 Mil.
Protect Pharmaceutical's EBIT for the trailing twelve months (TTM) ended in Jun. 2018 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Protect Pharmaceutical EV-to-EBIT Related Terms

Protect Pharmaceutical EV-to-EBIT Historical Data

* Premium members only.

The historical data trend for Protect Pharmaceutical's EV-to-EBIT can be seen below:

Protect Pharmaceutical EV-to-EBIT Chart

Protect Pharmaceutical Annual Data

Trend

Dec09

Dec10

Dec11

Dec12

Dec13

Dec14

Dec15

Dec16

Dec17

EV-to-EBIT

Get a 7-Day Free Trial

-83.29

-239.97

-21.48

-26.43

-8.60

Protect Pharmaceutical Quarterly Data
	Sep13	Dec13	Mar14	Jun14	Sep14	Dec14	Mar15	Jun15	Sep15	Dec15	Mar16	Jun16	Sep16	Dec16	Mar17	Jun17	Sep17	Dec17	Mar18	Jun18
EV-to-EBIT	Get a 7-Day Free Trial															-8.77	-6.97	-8.60	-8.23	-1,065.18

PRTT vs PVEG, FCIC, USAQ: EV-to-EBIT Comparison

For the Integrated Freight & Logistics subindustry, Protect Pharmaceutical's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Protect Pharmaceutical EV-to-EBIT vs Transportation Industry

For the Transportation industry and Industrials sector, Protect Pharmaceutical's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Protect Pharmaceutical's EV-to-EBIT falls into.

Save Embed

Protect Pharmaceutical EV-to-EBIT Calculation

Protect Pharmaceutical's EV-to-EBIT for today is calculated as:

EV-to-EBIT	=	Enterprise Value (Today)	/	EBIT (TTM)
	=	0.000	/	-0.001
	=	0.00

Protect Pharmaceutical's current Enterprise Value is $0.00 Mil.
Protect Pharmaceutical's EBIT for the trailing twelve months (TTM) ended in Jun. 2018 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.00 Mil.

Frequently Asked Questions Learn more about EV-to-EBIT →

What does a EV-to-EBIT of 0.00 mean?

Protect Pharmaceutical (PRTT) has a EV-to-EBIT of 0.00 as of Jul. 18, 2026. EV to EBIT ratio is the inverse of Joel Greenblatt's earnings yield definition. View historical data on Protect Pharmaceutical and its competitors.

Is Protect Pharmaceutical's EV-to-EBIT too high?

Protect Pharmaceutical's current EV-to-EBIT is 0.00.

How does Protect Pharmaceutical's EV-to-EBIT compare to PVEG and FCIC?

Protect Pharmaceutical's EV-to-EBIT of 0.00 can be compared against companies in the Transportation industry. The industry median EV-to-EBIT is 12.35. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.

What is a good EV-to-EBIT for a Transportation company?

The median EV-to-EBIT among Transportation companies is 12.35, based on 869 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-EBIT significantly above this median, while those in the bottom quartile fall well below. However, EV-to-EBIT should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.

What does a high EV-to-EBIT mean?

A high EV-to-EBIT can signal that a stock is expensive relative to its fundamentals. EV to EBIT ratio is the inverse of Joel Greenblatt's earnings yield definition. View historical data on Protect Pharmaceutical and its competitors. For the Transportation industry, the median EV-to-EBIT is 12.35 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Protect Pharmaceutical's current EV-to-EBIT is 0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.

Is Protect Pharmaceutical stock overvalued right now?

Protect Pharmaceutical (PRTT) has a current EV-to-EBIT of 0.00. The current EV-to-EBIT is 0.00. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.

How is EV-to-EBIT calculated?

EV-to-EBIT is calculated from a company's financial statements. For Protect Pharmaceutical (PRTT), the current EV-to-EBIT is 0.00 as of Jul. 18, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Protect Pharmaceutical Business Description

Industry Industrials Transportation

Comparable Companies TSXV:PMO.H PVEG FCIC TSXV:MUST.H BOM:531930 USAQ EZCL TSXV:MCN RLBY TSXV:GCCC ETNI CHWE BOM:538568 TSXV:WT.H KLMN BOM:519319 BOM:508963 BOM:539762 TSXV:STR.H MTLK

Address 30 N Gould St, Suite R, Sheridan, WY, USA, 82801

Website https://www.inaiapp.com

Protect Pharmaceutical Corp is engaged in Textiles and Software as a Service.